Resources search

International drug price indicator guide|Guia internacionale de indicadores de precios de medicamentos|Indicateur de prix internationaux des medicaments|2008

FRYE, Julie E
Ed
2009

Expand view

This guide contains a spectrum of prices from pharmaceutical suppliers, international development organisations, and government agencies. Its aim is to make price information more widely available in order to improve procurement of medicines of assured quality for the lowest possible price. Comparative price information is important for getting the best price, and this is an essential reference for anyone involved in the procurement of pharmaceuticals. This guide will help to: * Determine the probable cost of pharmaceutical products; * Compare current prices paid to prices available on the international market; * Plan budgets and programmes; * Assess the potential financial impact of changes to your current medicines list, and * Support rational medicines use education

Intellectual property rights and access to ARV medicines : civil society resistance in the global south|Brazil, Colombia, China, India, Thailand

REIS, Renata
TERTO, Veriano Jr
PIMENTA, Maria Cristina Pimenta
Eds
2009

Expand view

This book looks at "...the recent history and the many struggles related to advocacy for access to [antiretroviral] medicines of engaged civil society. Through the experiences of five middle-income countries - Brazil, China, Colombia, India, and Thailand." It presents "...the perspective of local civil society organisations about the national impact of intellectual property protection and access to medications. "These five countries were chosen due to their accumulated experience in this field, their capacity to produce generic medication, their activist efforts, and the exchange of ideas and information that already exists between them"

Measuring transparency to improve good governance in the public pharmaceutical sector : Jordan

NUSEIRAT, Adi
2009

Expand view

"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in Jordan. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In Jordan, the assessment looked at six functions: medicines registration, inspection of pharmaceutical establishments, promotion, selection, procurement and distribution"

Measuring transparency to improve good governance in the public pharmaceutical sector : Lebanon

HAMRA, Rasha
RAIDY, Collette
NAOUS, Maha
2009

Expand view

"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in Lebanon. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In Lebanon, the assessment looked at six functions: medicines registration, inspection of pharmaceutical establishments, promotion, selection, procurement and distribution"

Measuring transparency to improve good governance in the public pharmaceutical sector : Syrian Arab Republic

AL MARDINI, Amer
AL HAKEEM, Souheila
2009

Expand view

"This report presents the findings of the first phase of the [World Health Organization's] national Good Governance for Medicines programme in the Syrian Arab Republic. The assessment aims to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. In the Syrian Arab Republic, the assessment looked at eight functions: medicines registration, licensing of pharmaceutical establishments, inspection of pharmaceutical establishments, promotion, selection, clinical trials, procurement and distribution"

2009 FIP global pharmacy workforce report

WULIJI, Tana
Ed
2009

Expand view

"Without access to and appropriate use of quality medicines, health systems lose their ability to meet health care needs. The pharmacy workforce crisis threatens the ability of many countries to deliver health services, however little information or studies have been published in this area. The International Pharmaceutical Federation (FIP) has sought to address this crisis by gathering global baseline data on pharmacy workforce and developing evidence-based background papers to serve as an advocacy tool at country, regional and global levels"

10 health questions about the Caucasus and Central Asia

JAKUBOWSKI, Elke
ARNAUDOVA, Albena
2009

Expand view

This book highlights the essentials of health and health systems in eight countries in the region. It then compares these national data with the average data for three groups - their own, the 15 countries that were members of the European Union (EU) before 1 May 2004 and the 27 current EU Member States. Each chapter provides a concise overview of key health indicators in one of the eight countries, summarises the key features of the country's health system and describes the results of over a decade of health system reform

Enhanced global strategy for further reducing the disease burden due to leprosy (plan period: 2011-2015)

REGIONAL OFFICE FOR SOUTH EAST ASIA, WORLD HEALTH ORGANIZATION (WHO)
2009

Expand view

This document presents an overview of the concepts, ethics and guiding principles of the Enhanced Global Strategy. This is accompanied by the updated Operational Guidelines that outline practical suggestions for the implementation of leprosy control activities based on current evidence, professional knowledge and best practices. It is expected that these documents will assist leprosy-endemic countries in developing their own country-specific strategies and plans of action in order to sustain and provide high quality services to individuals and communities that need them

World malaria report 2009

WORLD HEALTH ORGANIZATION (WHO)
2009

Expand view

This report summarises information received from 108 malaria endemic countries and other sources and updates the analysis presented in the 2008 Report. It highlights progress made in meeting the World Health Assembly (WHA) targets for malaria to be achieved by 2010 and 2015, and new goals on malaria elimination contained in the Global Malaria Action Plan (2008)

WHO handbook on indoor radon : a public health perspective

ZEEB, Hajo
SHANNOUN, Ferid
2009

Expand view

This handbook focuses on residential radon exposure from a public health point of view and provides detailed recommendations on reducing health risks from radon and policy options for preventing and mitigating radon exposure. The material reflects the epidemiological evidence that indoor radon exposure is responsible for a substantial number of lung cancers in the general population

The global economic crisis and HIV prevention and treatment programmes : vulnerabilities and impact

BONNEL, Rene
DE BEYER, Joy
BENNETT, Dianne
2009

Expand view

This report summarises responses gathered, in late March 2009, from respondents in 71 countries. It asked whether antiretroviral treatment had been affected, or might be affected in future, by the global economic crisis. It identifies regions that appear to be more vulnerable than others and highlights the causes and negative effects of disruption to antiretroviral treatment programmes or services. The report suggests ways to maintain and expand access to HIV treatment in a difficult economic climate

Measuring transparency in the public pharmaceutical sector : assement instrument

BAGHDADI-SABETI, Guitelle
COHEN-KOHLER, John Clare
WONDEMAGEGNEHU, Eshetu
2009

Expand view

The objective of this instrument is to help stakeholders carry out assessments to measure the level of transparency and the vulnerability to corruption in selected areas of the public pharmaceutical sector. It provides an assessment methodology together with a questionnaire for national assessors to systematically collect information and perceptions through interviews of relevant health professionals in the public and private sectors

Diarrhoea : why children are still dying and what can be done

2009

Expand view

This website focuses on a package of proven prevention and treatment measures for diarrhoea. It is divided into sections which include: the global burden of diarrhoea, the basics of diarrhoeal diseases; where we stand today in preventing and treating childhood diarrhoea; and a seven-point plan for comprehensive diarrhoeal control. The website is a version of the UNICEF/WHO report 'Diarrhoea: why children are still dying and what can be done'. It would be useful to the general public, health workers, government, NGOs, United Nations organisations, policy makers and private sector workers

Diarrhoea : why children are still dying and what can be done

WHITE JOHANSSON, Emily
WARD, Tessa
et al
2009

Expand view

"The objective of this WHO/UNICEF report is to focus attention on the prevention and management of diarrhoeal diseases as central to improving child survival. It examines the latest available information on the burden and distribution of childhood diarrhoea. It also analyses how well countries are doing in making available key interventions proven to reduce its toll. Most importantly, it lays out a new strategy for diarrhoea control, one that is based on interventions drawn from different sectors that have demonstrated potential to save children’s lives. It sets out a 7-point plan that includes a treatment package to reduce childhood diarrhoea deaths, as well as a prevention package to make a lasting reduction in the diarrhoea burden in the medium to long term"

Community-based surveillance of antimicrobial use and resistance in resource-constrained settings|Report on five pilot projects

HOLLOWAY, Kathleen A
2009

Expand view

This document describes five pilot surveillance projects that were set up in India (three sites) and South Africa (two sites) with the aim of developing a model for undertaking integrated community-based surveillance in resource-constrained settings and generating baseline data. The methodology used in each area aimed to collect antimicrobial resistance (AMR) and use data from the same geographical area over time, but was modified to suit the particular characteristics of each site

Pharmacological treatment of mental disorders in primary health care

WORLD HEALTH ORGANIZATION (WHO)
2009

Expand view

This manual provides "evidence-based information to health care professionals in primary health care, especially in low- and middle-income countries, to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence"

South African national HIV prevalence, incidence, behavior and communication survey 2008 : turning a tide among teenagers ?

SHISANA, O
et al
2009

Expand view

"South Africa has the largest burden of HIV/AIDS and is currently implementing the largest antiretroviral treatment (ART) programme in the world. It is therefore fitting that South Africa is the first in the world to conduct three repeated national HIV population-based surveys to help monitor our response as a nation to the HIV/AIDS epidemic. This report is the third in a time series of population-based HIV seroprevalence surveys which started in 2002 and were repeated in 2005 and again in 2008"

Pages

E-bulletin